PDA and AAMI Announce Plans to Explore Collaborations 5 February, 2020

Bethesda, Md. – The Parenteral Drug Association (PDA) and the Association for the Advancement of Medical Instrumentation (AAMI) today announced their agreement to explore collaborations to further the missions of both organizations and enhance value to their members, stakeholders, and their respective communities at large. The two heads of each organization met at PDA’s headquarters on Jan. 29 to sign a collaboration agreement.

“This is a great opportunity to leverage the important work of both organizations,” said Richard Johnson, PDA President & CEO.

“We look forward to sharing with and learning from PDA’s staff and leaders to further both organization’s missions.” said Robert Jensen, AAMI President and CEO.

With similar missions and professional members in the pharmaceutical, biopharmaceutical and medical devices industries, AAMI and PDA see many areas in which the two groups can collaborate, including:

• Support joint projects
• Develop/evaluate common business systems
• Co-marketing publications, conferences and training courses
• Develop a joint meeting
• Offer members reduced price for joining other organization